verapamil has been researched along with Aortic Stenosis, Subvalvular in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Aortic Stenosis, Subvalvular: A pathological constriction occurring in the region below the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fixed subvalvular aortic stenosis is an uncommon cause of left ventricular outflow obstruction which occasionally can be found in association with dynamic muscular obstruction." | 1.28 | [Double subvalvular aortic stenosis (fixed and dynamic) diagnosed by ECHO-Doppler]. ( Azpitarte, J; Calleja, M; Rodríguez Bailón, I; Tercedor, L, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halawa, B | 1 |
| Mazurek, W | 1 |
| Rosing, DR | 1 |
| Kent, KM | 1 |
| Maron, BJ | 1 |
| Condit, J | 1 |
| Epstein, SE | 1 |
| Rodríguez Bailón, I | 1 |
| Tercedor, L | 1 |
| Calleja, M | 1 |
| Azpitarte, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy-- a Multicenter Randomized Control Trial[NCT02948998] | Phase 4 | 260 participants (Anticipated) | Interventional | 2018-05-14 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for verapamil and Aortic Stenosis, Subvalvular
| Article | Year |
|---|---|
[Cardiomyopathies and their treatment].
Topics: Adult; Aged; Aortic Stenosis, Subvalvular; Cardiomegaly; Cardiomyopathies; Cardiomyopathy, Alcoholic | 1980 |
1 trial available for verapamil and Aortic Stenosis, Subvalvular
| Article | Year |
|---|---|
Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy.
Topics: Adult; Aged; Aortic Stenosis, Subvalvular; Blood Pressure; Cardiac Output; Cardiomyopathy, Hypertrop | 1980 |
1 other study available for verapamil and Aortic Stenosis, Subvalvular
| Article | Year |
|---|---|
[Double subvalvular aortic stenosis (fixed and dynamic) diagnosed by ECHO-Doppler].
Topics: Adult; Aortic Stenosis, Subvalvular; Echocardiography, Doppler; Humans; Male; Postoperative Care; Ve | 1991 |